Processa Pharmaceuticals, Inc. (PCSA) Insider Trading
Sector: Pharmaceuticals · Market Cap: $5M · 1 insider purchase in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER | Δ OWNED | FILING |
|---|---|---|---|---|---|---|---|
| Young David Pres. Research & Development | Jun 30, 2026 | 2,531 | $1.93 | $5K | 21,729 | +13.2% |
Want more?
Sign up free to see 30+ days of history, set alerts, and track PCSA on your watchlist.
Start for FreeAbout Processa Pharmaceuticals, Inc. Insider Trading
6 insiders at Processa Pharmaceuticals, Inc. (PCSA) have purchased stock in the past 90 days, totaling $105K across 21 transactions (37,753 shares).
The most recent purchase was by Pres. Research & Development Young David on June 30, 2026 — a $5K buy of 2,531 shares at $1.93, bringing his total holdings to 21,729 shares.
Insiders who purchased: Young David (Pres. Research & Development, 5 buys totaling $23K); Ng George K (CEO, 4 buys totaling $22K); SKIBSTED RUSSELL (CFO, 3 buys totaling $18K); Bigora Sian (Chief Development Officer, 3 buys totaling $16K); Guy Wendy (Chief Administrative Officer, 3 buys totaling $14K); Lin Patrick (Chief Business - Strategy Off, 3 buys totaling $12K).
This level of insider buying appears elevated compared to PCSA's typical activity — there were 9 purchases in the prior nine months.
PCSA is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $5M.
With 6 different insiders buying in the same 90-day window, this qualifies as cluster buying at PCSA — a pattern that research suggests can signal conviction among management.
Track PCSA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.